PDK1 shRNA

PDK1 shRNA is a gene-silencing therapeutic approach designed to inhibit the expression of 3-phosphoinositide-dependent protein kinase 1 (PDK1). PDK1 is a master regulator of the PI3K/AKT signaling pathway, specifically responsible for the phosphorylation of AKT at the Thr308 residue. In the context of acute leukemia, PDK1-mediated AKT activation is crucial for the maintenance and proliferation of leukemic blasts, particularly within the protective bone marrow microenvironment. By utilizing retroviral vectors to deliver shRNA constructs, researchers can suppress PDK1 transcription, leading to diminished proliferation and reduced tumor engraftment in preclinical models of acute myeloid leukemia (AML).

Other names

PDK1-shRNAPDK-1-shRNAPDK 1-shRNAshort hairpin RNA targeting PDK1